Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study

BACKGROUND: Hepatitis C virus (HCV) infection is increasing among pregnant women because of the opioid epidemic, yet there are no interventions to reduce perinatal HCV transmission or to treat HCV during pregnancy. Physiological changes in pregnancy alter the pharmacokinetics of some medications; th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chappell, Catherine A, Scarsi, Kimberly K, Kirby, Brian J, Suri, Vithika, Gaggar, Anuj, Bogen, Debra L, Macio, Ingrid S, Meyn, Leslie A, Bunge, Katherine E, Krans, Elizabeth E, Hillier, Sharon L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491553/
https://www.ncbi.nlm.nih.gov/pubmed/32939459
http://dx.doi.org/10.1016/S2666-5247(20)30062-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491553/
https://www.ncbi.nlm.nih.gov/pubmed/32939459
http://dx.doi.org/10.1016/S2666-5247(20)30062-8

Ejemplares similares